Mundipharma International Limited
GPTKB entity
Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:foundedYear |
1967
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mundipharma International Limited
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Raman_Singh
|
| gptkbp:notableProduct |
gptkb:Betadine
gptkb:Nexthaler gptkb:Penthrox gptkb:Targinact gptkb:OxyContin |
| gptkbp:operatesIn |
gptkb:Africa
gptkb:Asia gptkb:Europe gptkb:Latin_America gptkb:Middle_East |
| gptkbp:parentCompany |
gptkb:Mundipharma_AG
|
| gptkbp:products |
pain management medications
respiratory medicines oncology treatments |
| gptkbp:servesArea |
global
|
| gptkbp:subsidiary |
gptkb:Sackler_family
|
| gptkbp:website |
https://www.mundipharma.com/
|
| gptkbp:bfsParent |
gptkb:Mundipharma
|
| gptkbp:bfsLayer |
7
|